Risk Stratifi cation in Severe Sepsis: Organ Failure Scores or PIRO?

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/978-3-642-00479-7_2
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• A prospective, observational registry of patients with severe sepsis: The Canadian Sepsis Treatment and Response Registry*

  2009cited by this paper
• PIRO score for community-acquired pneumonia: A new prediction rule for assessment of severity in intensive care unit patients with community-acquired pneumonia*

  2009cited by this paper
• Epidemiology of sepsis

  2008cited by this paper
• The ventilator-associated pneumonia PIRO score: a tool for predicting ICU mortality and health-care resources use in ventilator-associated pneumonia.

  2008cited by this paper
• Design, conduct, analysis and reporting of a multi-national placebo-controlled trial of activated protein C for persistent septic shock

  2008cited by this paper
• Design, conduct, analysis and reporting of a multi-national placebo-controlled trial of activated protein C for persistent septic shock

  2008cited by this paper
• Sepsis mortality prediction based on predisposition, infection and response

  2008cited by this paper
• Hydrocortisone therapy for patients with septic shock.

  2008cited by this paper
• Use of Drotrecogin alfa (activated) in Italian intensive care units: the results of a nationwide survey

  2007cited by this paper
• Increasing evidence that the risks of rhAPC may outweigh its benefits

  2007cited by this paper
• The Changing Prognostic Determinants in the Critically Ill Patient

  2007cited by this paper
• Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008

  2007cited by this paper
• 2007 Yearbook of Intensive Care and Emergency Medicine

  2007cited by this paper
• Evaluating the use of Drotrecogin alfa (activated) in adult severe sepsis: a Canadian multicenter observational study

  2007cited by this paper
• The epidemiology of severe sepsis in England, Wales and Northern Ireland, 1996 to 2004: secondary analysis of a high quality clinical database, the ICNARC Case Mix Programme Database

  2006cited by this paper
• SAPS 3—From evaluation of the patient to evaluation of the intensive care unit.Part 2: Development of a prognostic model for hospital mortality at ICU admission

  2006cited by this paper
• Systemic inflammatory response and progression to severe sepsis in critically ill infected patients.

  2005cited by this paper
• Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death.

  2005cited by this paper
• Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death.

  2005cited by this paper
• SAPS 3--From evaluation of the patient to evaluation of the intensive care unit. Part 1: Objectives, methods and cohort description.

  2005cited by this paper
• Dynamic microsimulation to model multiple outcomes in cohorts of critically ill patients

  2004cited by this paper
• Epidemiology of sepsis in Norway in 1999

  2004cited by this paper
• Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab′)2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels*

  2004cited by this paper
• SEPSIS MORTALITY PREDICTION BASED ON PREDISPOSITION, INFECTION, RESPONSE AND ORGAN DYSFUNCTION (PIRO): 518

  2004cited by this paper
• Mortality rate and length of stay of patients admitted to the intensive care unit in July*

  2004cited by this paper
• Measures, markers, and mediators: Toward a staging system for clinical sepsis. A Report of the Fifth Toronto Sepsis Roundtable, Toronto, Ontario, Canada, October 25–26, 2000

  2003cited by this paper
• The epidemiology of sepsis in the United States from 1979 through 2000.

  2003cited by this paper
• 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference

  2003cited by this paper
• The PIRO concept: I is for infection

  2003cited by this paper
• The PIRO concept: P is for predisposition

  2003cited by this paper
• The PIRO Concept: R is for response

  2003cited by this paper
• Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock

  2003cited by this paper
• The PIRO Concept: O is for organ dysfunction

  2003cited by this paper
• Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis

  2003cited by this paper
• Influence of systemic inflammatory response syndrome and sepsis on outcome of critically ill infected patients.

  2003cited by this paper
• Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.

  2002cited by this paper
• Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study

  2002cited by this paper
• Recombinant human activated protein C for severe sepsis.

  2001cited by this paper
• Usefulness of a strategy based on bronchoscopy with direct examination of bronchoalveolar lavage fluid in the initial antibiotic therapy of suspected ventilator-associated pneumonia

  2001cited by this paper
• Accuracy of a composite score using daily SAPS II and LOD scores for predicting hospital mortality in ICU patients hospitalized for more than 72 h

  2001cited by this paper
• Efficacy and safety of recombinant human activated protein C for severe sepsis.

  2001cited by this paper
• Serial evaluation of the SOFA score to predict outcome in critically ill patients.

  2001cited by this paper
• New strategies for clinical trials in patients with sepsis and septic shock

  2001cited by this paper
• The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study

  1999cited by this paper
• The epidemiology of bacterial sepsis.

  1999cited by this paper
• Dear SIRS, I'm sorry to say that I don't like you...

  1997cited by this paper
• The Logistic Organ Dysfunction System

  1997cited by this paper
• The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure

  1996influential reference
• The Logistic Organ Dysfunction system. A new way to assess organ dysfunction in the intensive care unit. ICU Scoring Group.

  1996cited by this paper
• The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study.

  1995cited by this paper
• Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome.

  1995cited by this paper
• Customized probability models for early severe sepsis in adult intensive care patients. Intensive Care Unit Scoring Group.

  1995cited by this paper
• Round table conference on clinical trials for the treatment of sepsis.

  1995cited by this paper
• Yearbook of Intensive Care and Emergency Medicine

  1995cited by this paper
• Round table conference on clinical trials for the treatment of sepsis Brussels, March 12–14, 1994

  1995cited by this paper
• Should morbidity replace mortality as an endpoint for clinical trials in intensive care?

  1995cited by this paper
• Sepsis: Current Perspectives in Pathophysiology and Therapy

  1994cited by this paper
• What Determines Prognosis in Sepsis? Evidence for a Comprehensive Individual Patient Risk Assessment Approach to the Design and Analysis of Clinical Trials

  1994cited by this paper
• The clinical evaluation of new drugs for sepsis. A prospective study design based on survival analysis.

  1993cited by this paper
• Predicting outcome among intensive care unit patients using computerised trend analysis of daily Apache II scores corrected for organ system failure

  1988cited by this paper
• Assessing hospital-associated deaths from discharge data. The role of length of stay and comorbidities.

  1988cited by this paper
• The epidemiology of sepsis.

  1973cited by this paper

• Development and Validation of a Disease Severity Scoring Model for Pediatric Sepsis

  2016cites this paper
• Understanding the PIRO concept: from theory to clinical practice - part 2.

  2010cites this paper